Samsung Epis Holdings Delivers Business Updates at the 44th J.P. Morgan Healthcare Conference
Kyung-Ah Kim, President and Chief Executive Officer (CEO) of Samsung Epis Holdings Samsung Bioepis plans to secure 20…
Samsung Bioepis and Biogen Receive European Commission (EC)
OPUVIZâ„¢ is one of the first wave aflibercept biosimilars in EuropeOPUVIZ is the second European Commission (EC)-approved ophthalmology…